News

News
Partner news

Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.

Read full story
Partner news

Zebra Medical Vision Announces Agreement With DePuy Synthes to Deploy Cloud Based Artificial Intelligence Orthopaedic Surgical Planning Tools

Read full story
Partner news

BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD

Read full story
Partner news

Vect-Horus Announces Agreement With Johnson & Johnson Innovation

Read full story
Partner news

Accelerator Corporation Announces $7M Series A Investment in ApoGen Biotechnologies to Develop a New Class of Drugs Targeting Resistance to Cancer Therapy

Read full story
Partner news

Navitor Pharmaceuticals Announces $33 Million Series B Financing

Read full story
Partner news

Tetra Discovery Initiates Phase 1 Study of BPN14770, Under Development for Treatment and Prevention of Alzheimer's Disease

Read full story
Partner news

MacroGenics Enters Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies

Read full story
Partner news

Padlock Therapeutics Secures $23 Million Series A Financing

Read full story
Partner news

Aquinox Pharmaceuticals Commences Phase 2 Clinical Trial of AQX-1125 in Chronic Obstructive Pulmonary Disease

Read full story
Partner news

Celladon Corporation Announces Receipt of EMA Scientific Advice for MYDICAR® and Initiation of AGENT-HF Trial

Read full story
Partner news

Genocea Biosciences Initiates Phase 1 Study of Vaccine Candidate GEN-004 to Prevent Infections Caused By Pneumococcus

Read full story
Partner news

Biocartis Completes €34,5 Million ($44,5 Million) Series D Fund Raising

Read full story
Partner news

23andMe Raises More than $50 Million in New Financing

Read full story
Partner news

PhaseBio Positions for the Next Stage of Development by Bringing on Board Industry Veteran, Jonathan Mow as Chief Business Officer

Read full story